幽门螺杆菌筛查与根除预防胃癌:台北全球共识
28位来自11个国家的专家采用德尔菲法和GRADE方法,就人群幽门螺杆菌筛查与根除预防胃癌达成26条共识。共识认为根除治疗应提供给所有感染者,高危人群应考虑大规模筛查与根除,年轻成人筛查治疗最具成本效益。
要点
- 根除幽门螺杆菌可降低无症状者胃癌风险,推荐用于感染者。
- 高胃癌发病率地区年轻成人筛查治疗最具成本效益。
- 根除后高级别胃萎缩或肠化生者应接受监测内镜。
核心结论
- 证据支持根除治疗应提供给所有幽门螺杆菌感染者。
- 易感人群应检测,阳性者应治疗。
- 胃癌高风险人群应考虑大规模筛查和根除幽门螺杆菌。
研究设计与样本
- 全球共识会议,28位来自11个国家的专家审阅证据。
- 采用德尔菲法修改声明,共识水平预定义为每条声明≥80%同意。
- 遵循推荐分级的评估、制定与评价(GRADE)方法。
主要发现
- 26条声明达成共识。
- 无症状者根除幽门螺杆菌可降低胃癌风险。
- 早期胃癌内镜切除后根除幽门螺杆菌可降低异时性癌风险。
- 高胃癌发病率地区年轻成人筛查治疗最具成本效益。
- 该策略在50岁以上人群中可能仍有效。
关键数值与推荐
- 根除幽门螺杆菌推荐用于无症状者,除非有竞争性考虑。
- 易感人群(如胃癌患者一级亲属)筛查治疗有益。
- 筛查治疗推荐最好在萎缩性胃炎和肠化生发生前进行。
- 推荐基于抗生素管理原则的当地有效方案。
- 高级别胃萎缩或肠化生者根除后应接受监测内镜。
临床怎么用
- 根除治疗应提供给所有幽门螺杆菌感染者。
- 易感人群应检测,阳性者应治疗。
- 胃癌高风险人群应考虑大规模筛查和根除。
- 筛查治疗可整合或纳入国家医疗优先项目如结直肠癌筛查以优化资源。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A global consensus meeting was held to review current evidence and knowledge gaps and propose collaborative studies on population-wide screening and eradication of Helicobacter pylori for prevention of gastric cancer (GC). METHODS: 28 experts from 11 countries reviewed the evidence and modified the statements using the Delphi method, with consensus level predefined as ≥80% of agreement on each statement. The Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach was followed. RESULTS: Consensus was reached in 26 statements. At an individual level, eradication of H. pylori reduces the risk of GC in asymptomatic subjects and is recommended unless there are competing considerations. In cohorts of vulnerable subjects (eg, first-degree relatives of patients with GC), a screen-and-treat strategy is also beneficial. H. pylori eradication in patients with early GC after curative endoscopic resection reduces the risk of metachronous cancer and calls for a re-examination on the hypothesis of 'the point of no return'. At the general population level, the strategy of screen-and-treat for H. pylori infection is most cost-effective in young adults in regions with a high incidence of GC and is recommended preferably before the development of atrophic gastritis and intestinal metaplasia. However, such a strategy may still be effective in people aged over 50, and may be integrated or included into national healthcare priorities, such as colorectal cancer screening programmes, to optimise the resources. Reliable locally effective regimens based on the principles of antibiotic stewardship are recommended. Subjects at higher risk of GC, such as those with advanced gastric atrophy or intestinal metaplasia, should receive surveillance endoscopy after eradication of H. pylori. CONCLUSION: Evidence supports the proposal that eradication therapy should be offered to all individuals infected with H. pylori. Vulnerable subjects should be tested, and treated if the test is positive. Mass screening and eradication of H. pylori should be considered in populations at higher risk of GC.
引用
- Liou JM, Malfertheiner P, Lee YC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020. PMID: 33004546. doi:10.1136/gutjnl-2020-322368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。